| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 14, 2025 | CERS Cerus Corp | Green Kevin Dennis71 | Chief Financial Officer | Sell | 59,887 | $1.45 | $86,836.15 | -3.2% | -5.5% | +16.6% | |
| Mar 14, 2025 | CERS Cerus Corp | Benjamin Richard J71 | Chief Medical Officer | Sell | 49,024 | $1.45 | $71,084.80 | -3.4% | -5.5% | +16.6% | |
| Mar 14, 2025 | VMD Viemed Healthcare, Inc. | Smokoff Timothy45 | Director | Sell | 11,865 | $7.70 | $91,363.75 | -2.8% | -10.4% | +21.5% | |
| Mar 14, 2025 | MYO Myomo, Inc. | Mitchell Micah75 | Chief Commercial Officer | Sell | 48,000 | $5.16 | $247,564.80 | -25.5% | -46.1% | -86.6% | |
| Mar 13, 2025 | ISRG Intuitive Surgical Inc | Desantis Robert49 | EVP &Chief Strategy &Corp Op | Sell | 11,545 | $499.22 | $5,763,485.48 | -10.7% | +9.6% | -1.0% | |
| Mar 13, 2025 | MYO Myomo, Inc. | Kirk Thomas F55 | Director | Buy | 7,400 | $5.00 | $37,000.00 | +3.0% | -43.6% | -86.3% | |
| Mar 13, 2025 | EW Edwards Lifesciences Corp | Bobo Donald E Jr64 | Cvp,Strategy/ Corp Development | Sell | 9,500 | $67.96 | $645,623.80 | -16.8% | +11.1% | +20.4% | |
| Mar 13, 2025 | LMAT Lemaitre Vascular Inc | Kamke Trent G53 | Senior V. P., Operations | Sell | 6,529 | $80.42 | $525,052.56 | -44.5% | +5.5% | +37.1% | |
| Mar 13, 2025 | SGHT Sight Sciences, Inc. | Raheja Manohar K.73 | EVP, Research &Development | Buy | 20,000 | $2.66 | $53,250.00 | +7.1% | +74.2% | +52.6% | |
| Mar 12, 2025 | RXST Rxsight, Inc. | Fountain Tamara | Director | Sell | 7,000 | $25.71 | $180,001.50 | -22.0% | -39.8% | -70.7% | |
| Mar 12, 2025 | DXCM Dexcom Inc | Leach Jacob Steven55 | EVP, Chief Operating Officer | Sell | 14,076 | $70.38 | $990,670.29 | -4.3% | +19.9% | -7.8% | |
| Mar 12, 2025 | NXL Nexalin Technology, Inc. | Shelton Carolyn Hamby | Sr. VP - Quality, Regulatory | Buy | 6,000 | $2.20 | $13,200.00 | +25.0% | -44.2% | -81.8% | |
| Mar 12, 2025 | DXCM Dexcom Inc | Brown Michael Jon72 | EVP, Chief Legal Officer | Sell | 13,000 | $70.38 | $914,941.30 | -11.0% | +19.9% | -7.8% | |
| Mar 12, 2025 | DXCM Dexcom Inc | Stern Sadie72 | EVP, Chief Hr Officer | Sell | 11,176 | $70.38 | $786,568.00 | -8.8% | +19.9% | -7.8% | |
| Mar 12, 2025 | DXCM Dexcom Inc | Sylvain Jereme M65 | EVP, Chief Financal Officer | Sell | 12,001 | $70.38 | $844,631.58 | -8.9% | +19.9% | -7.8% | |
| Mar 12, 2025 | DXCM Dexcom Inc | Sayer Kevin R62 | Chairman, CEO &President | Sell | 32,498 | $70.38 | $2,287,212.49 | -8.0% | +19.9% | -7.8% | |
| Mar 12, 2025 | BDX Becton Dickinson & Co | Byrd Richard64 | EVP &President Interventional | Sell | 1,940 | $224.91 | $436,325.40 | -20.7% | -21.6% | -7.7% | |
| Mar 12, 2025 | ISRG Intuitive Surgical Inc | Miller Brian Edward | EVP &Chief Digital Officer | Sell | 12,900 | $493.44 | $6,365,341.73 | -23.3% | +6.5% | -3.6% | |
| Mar 12, 2025 | BLFS Biolife Solutions Inc | Aebersold Sarah60 | Chief Human Resources Officer | Sell | 8,415 | $26.17 | $220,189.16 | -7.1% | -9.0% | -30.9% | |
| Mar 12, 2025 | MYO Myomo, Inc. | Kovelman Harry68 | Chief Medical Officer | Sell | 30,000 | $5.50 | $165,018.00 | -23.4% | -47.0% | -87.3% | |
| Mar 11, 2025 | AORT Artivion, Inc. | Davis John E | Chief Commercial Officer | Sell | 15,100 | $23.61 | $356,548.75 | -6.7% | +24.3% | +54.8% | |
| Mar 11, 2025 | BLFS Biolife Solutions Inc | Wichterman Troy60 | Chief Financial Officer | Sell | 4,151 | $25.00 | $103,775.00 | -3.4% | -10.4% | -28.6% | |
| Mar 11, 2025 | BLFS Biolife Solutions Inc | Foster Karen A.68 | Chief Quality And Operations | Sell | 1,331 | $25.00 | $33,275.00 | -0.9% | -10.4% | -28.6% | |
| Mar 11, 2025 | BLFS Biolife Solutions Inc | Berard Todd67 | Chief Marketing Officer | Sell | 1,577 | $25.00 | $39,425.00 | -1.5% | -10.4% | -28.6% | |
| Mar 11, 2025 | AORT Artivion, Inc. | Holloway Jean F49 | SVP, General Counsel | Sell | 18,020 | $23.61 | $425,509.86 | -8.4% | +24.3% | +54.8% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.